OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Cardiovascular safety, cancer and Jak-inhibitors: Differences to be highlighted
Maurizio Benucci, Arianna Damiani, Maria Infantino, et al.
Pharmacological Research (2022) Vol. 183, pp. 106359-106359
Closed Access | Times Cited: 28
Maurizio Benucci, Arianna Damiani, Maria Infantino, et al.
Pharmacological Research (2022) Vol. 183, pp. 106359-106359
Closed Access | Times Cited: 28
Showing 1-25 of 28 citing articles:
Evolving cognition of the JAK-STAT signaling pathway: autoimmune disorders and cancer
Xue Chen, Qinfan Yao, Xinyu Gu, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 195
Xue Chen, Qinfan Yao, Xinyu Gu, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 195
JAK inhibitors and autoimmune rheumatic diseases
Maurizio Benucci, Pamela Bernardini, Carmela Coccia, et al.
Autoimmunity Reviews (2023) Vol. 22, Iss. 4, pp. 103276-103276
Open Access | Times Cited: 64
Maurizio Benucci, Pamela Bernardini, Carmela Coccia, et al.
Autoimmunity Reviews (2023) Vol. 22, Iss. 4, pp. 103276-103276
Open Access | Times Cited: 64
Alopecia Areata: Current Treatments and New Directions
Dante Dahabreh, Seungyeon Jung, Yael Renert‐Yuval, et al.
American Journal of Clinical Dermatology (2023) Vol. 24, Iss. 6, pp. 895-912
Closed Access | Times Cited: 32
Dante Dahabreh, Seungyeon Jung, Yael Renert‐Yuval, et al.
American Journal of Clinical Dermatology (2023) Vol. 24, Iss. 6, pp. 895-912
Closed Access | Times Cited: 32
The JAK-STAT Pathway as a Therapeutic Strategy in Cancer Patients with Immune Checkpoint Inhibitor-Induced Colitis: A Narrative Review
Antonietta Gerarda Gravina, Raffaele Pellegrino, Alfonso Esposito, et al.
Cancers (2024) Vol. 16, Iss. 3, pp. 611-611
Open Access | Times Cited: 13
Antonietta Gerarda Gravina, Raffaele Pellegrino, Alfonso Esposito, et al.
Cancers (2024) Vol. 16, Iss. 3, pp. 611-611
Open Access | Times Cited: 13
L-theanine alleviates myocardial ischemia/reperfusion injury by suppressing oxidative stress and apoptosis through activation of the JAK2/STAT3 pathway in mice
Qi Li, Jiaqi Ding, Boyu Xia, et al.
Molecular Medicine (2024) Vol. 30, Iss. 1
Open Access | Times Cited: 12
Qi Li, Jiaqi Ding, Boyu Xia, et al.
Molecular Medicine (2024) Vol. 30, Iss. 1
Open Access | Times Cited: 12
Preventing and managing cardiovascular events in patients with inflammatory bowel diseases treated with small-molecule drugs, an international Delphi consensus
Pablo A. Olivera, Axel Dignaß, Marla C. Dubinsky, et al.
Digestive and Liver Disease (2024) Vol. 56, Iss. 8, pp. 1270-1280
Open Access | Times Cited: 6
Pablo A. Olivera, Axel Dignaß, Marla C. Dubinsky, et al.
Digestive and Liver Disease (2024) Vol. 56, Iss. 8, pp. 1270-1280
Open Access | Times Cited: 6
Cardiovascular safety of Janus kinase inhibitors in patients with rheumatoid arthritis: systematic review and network meta-analysis
Qiang‐hua Wei, Hui Wang, Jianglin Zhao, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 14
Qiang‐hua Wei, Hui Wang, Jianglin Zhao, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 14
Potential applications of JAK inhibitors, clinically approved drugs against autoimmune diseases, in cancer therapy
Xiaohuan Wei, Yuanyuan Liu
Frontiers in Pharmacology (2024) Vol. 14
Open Access | Times Cited: 5
Xiaohuan Wei, Yuanyuan Liu
Frontiers in Pharmacology (2024) Vol. 14
Open Access | Times Cited: 5
3,6-Anhydro-L-galactose suppresses mouse lymphocyte proliferation by attenuating JAK-STAT growth factor signal transduction and G1-S cell cycle progression
Shin Young Park, Ki Yun Kim, Won Young Jang, et al.
International Immunopharmacology (2025) Vol. 147, pp. 113998-113998
Open Access
Shin Young Park, Ki Yun Kim, Won Young Jang, et al.
International Immunopharmacology (2025) Vol. 147, pp. 113998-113998
Open Access
JAK Inhibitors and B Cell Function: A Comparative Study of Their Impact on Plasma Cell Differentiation, Cytokine Production, and Naïve B Cell Activation
Wenqi Huang, Charlotte de Vries, Ravi Sharma, et al.
European Journal of Immunology (2025) Vol. 55, Iss. 3
Open Access
Wenqi Huang, Charlotte de Vries, Ravi Sharma, et al.
European Journal of Immunology (2025) Vol. 55, Iss. 3
Open Access
Exploring Novel Therapies for Idiopathic Inflammatory Myopathies and Examining Future Perspectives
Luciana Molinero, Joan Padrosa, Iago Pinal‐Fernandez, et al.
Current Treatment Options in Rheumatology (2025) Vol. 11, Iss. 1
Closed Access
Luciana Molinero, Joan Padrosa, Iago Pinal‐Fernandez, et al.
Current Treatment Options in Rheumatology (2025) Vol. 11, Iss. 1
Closed Access
Lipocalin-2 promotes NSCLC progression by activating the JAK2/STAT3 signaling pathway
Jinjin Zhang, Qin Xu, Gengyun Sun
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access
Jinjin Zhang, Qin Xu, Gengyun Sun
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access
Targeting leucine-rich PPR motif-containing protein/LRPPRC by 5,7,4′-trimethoxyflavone suppresses esophageal squamous cell carcinoma progression
Hui Liu, Yubing Zhou, Mangaladoss Fredimoses, et al.
International Journal of Biological Macromolecules (2024) Vol. 269, pp. 131966-131966
Open Access | Times Cited: 4
Hui Liu, Yubing Zhou, Mangaladoss Fredimoses, et al.
International Journal of Biological Macromolecules (2024) Vol. 269, pp. 131966-131966
Open Access | Times Cited: 4
Tetrastigma hemsleyanum polysaccharide ameliorates cytokine storm syndrome via the IFN-γ-JAK2/STAT pathway
Siyu Fu, Xiaodan Bao, Zian Mao, et al.
International Journal of Biological Macromolecules (2024) Vol. 275, pp. 133427-133427
Closed Access | Times Cited: 4
Siyu Fu, Xiaodan Bao, Zian Mao, et al.
International Journal of Biological Macromolecules (2024) Vol. 275, pp. 133427-133427
Closed Access | Times Cited: 4
Efficacy and Safety of Upadacitinib in Rheumatoid Arthritis: Real-Life Experience from a Prospective Longitudinal Multicentric Study
Caterina Baldi, Simone Parisi, Paolo Falsetti, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 2, pp. 401-401
Open Access | Times Cited: 3
Caterina Baldi, Simone Parisi, Paolo Falsetti, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 2, pp. 401-401
Open Access | Times Cited: 3
Where are we now in biologic drugs for myositis?
Ana Neves, Luísa Viveiros, Veronica Venturelli, et al.
Lara D. Veeken (2024) Vol. 63, Iss. 11, pp. 2938-2947
Open Access | Times Cited: 3
Ana Neves, Luísa Viveiros, Veronica Venturelli, et al.
Lara D. Veeken (2024) Vol. 63, Iss. 11, pp. 2938-2947
Open Access | Times Cited: 3
Circular RNAs and the JAK/STAT pathway: New frontiers in cancer therapeutics
Waleed Hassan Almalki, Salem Salman Almujri
Pathology - Research and Practice (2024) Vol. 260, pp. 155408-155408
Closed Access | Times Cited: 2
Waleed Hassan Almalki, Salem Salman Almujri
Pathology - Research and Practice (2024) Vol. 260, pp. 155408-155408
Closed Access | Times Cited: 2
A novel highly selective allosteric inhibitor of tyrosine kinase 2 (TYK2) can block inflammation- and autoimmune-related pathways
Celia X.-J. Chen, Wei Zhang, Shulan Qu, et al.
Cell Communication and Signaling (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 5
Celia X.-J. Chen, Wei Zhang, Shulan Qu, et al.
Cell Communication and Signaling (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 5
Multi-omics analysis uncovered systemic lupus erythematosus and COVID-19 crosstalk
Zekai Nian, Yicheng Mao, Zexia Xu, et al.
Molecular Medicine (2024) Vol. 30, Iss. 1
Open Access | Times Cited: 1
Zekai Nian, Yicheng Mao, Zexia Xu, et al.
Molecular Medicine (2024) Vol. 30, Iss. 1
Open Access | Times Cited: 1
Analysis of related factors for RA flares after SARS-CoV-2 infection: a retrospective study from patient survey
Rong Li, Zhao Junkang, Qian Li, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access
Rong Li, Zhao Junkang, Qian Li, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access
Prevalence of Cardiovascular and Cancer Risk Factors Among Rheumatoid Arthritis Patients Prescribed Janus Kinase Inhibitors and Tumor Necrosis Factor Inhibitors: A Cross‐Sectional Study
Jud C. Janak, Ryan D. Ross, Brenna L. Brady, et al.
Arthritis Care & Research (2024) Vol. 76, Iss. 9, pp. 1287-1293
Open Access
Jud C. Janak, Ryan D. Ross, Brenna L. Brady, et al.
Arthritis Care & Research (2024) Vol. 76, Iss. 9, pp. 1287-1293
Open Access
Upadacitinib for axial spondyloarthritis: a meta-analysis of efficacy and safety
HanMing Tang, XiaoChen Liu, Jie Zhao, et al.
Clinical Rheumatology (2024) Vol. 43, Iss. 8, pp. 2391-2402
Closed Access
HanMing Tang, XiaoChen Liu, Jie Zhao, et al.
Clinical Rheumatology (2024) Vol. 43, Iss. 8, pp. 2391-2402
Closed Access
Risks of malignancies related to disease-modifying antirheumatic drugs in rheumatoid arthritis: a pharmacovigilance analysis using the FAERS database
Wan Xiong, Jianping Li, Lin Hu, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access
Wan Xiong, Jianping Li, Lin Hu, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access
The growing potential of tofacitinib in immune checkpoint inhibitor-induced colitis: identifying remaining puzzle pieces
Raffaele Pellegrino, Giovanna Palladino, Giuseppe Imperio, et al.
Exploration of Immunology (2024), pp. 770-779
Open Access
Raffaele Pellegrino, Giovanna Palladino, Giuseppe Imperio, et al.
Exploration of Immunology (2024), pp. 770-779
Open Access
Pharmaceutical aspects of JAK inhibitors: a comparative review
Sandhya Jinesh, Rajan Radhakrishnan
Inflammopharmacology (2024)
Closed Access
Sandhya Jinesh, Rajan Radhakrishnan
Inflammopharmacology (2024)
Closed Access
